-
[show abstract]
[hide abstract]
ABSTRACT: This paper presents an overview of development of a novel disposable plastic biochip for multiplexed clinical diagnostic applications.
The disposable biochip is manufactured using a low-cost, rapid turn- around injection moulding process and consists of nine
parabolic elements on a planar substrate. The optical elements are based on supercritical angle fluorescence (SAF) which provides
substantial enhancement of the fluorescence collection efficiency but also confines the fluorescence detection volume strictly
to the immediate proximity of the biochip surface, thereby having the potential to discriminate against background fluorescence
from the analyte solution. An optical reader is also described that enables interrogation and fluorescence collection from
the nine optical elements on the chip. The sensitivity of the system was determined with a biotin-avidin assay while its clinical
utility was demonstrated in an assay for C-reactive protein (CRP), an inflammation marker.
KeywordsLab on a chip–Supercritical angle fluorescence–Immunoassay–Cardiac marker
Biomedical Microdevices 04/2012; 13(4):759-767. · 3.03 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Surface plasmon resonance (SPR) is now widely embraced as a technology for monitoring a diverse range of protein-protein interactions and is considered almost de rigueur for characterizing antibody-antigen interactions. The technique obviates the need to label either of the interacting species and the binding event is visualized in real-time. Thus, it is ideally suited for screening crude, unpurified antibody samples that dominate early candidate panels following antibody selection campaigns. SPR returns both concentration and affinity data but when used correctly can also resolve the discrete component kinetic parameters (association and dissociation rate constants) of the affinity interaction. Herein, we outline some SPR-based generic antibody screening configurations and methodologies in the context of expediting data-rich ranking of candidate antibody panels and ensuring that antibodies with the optimal kinetic binding characteristics are reliably identified.
Methods in molecular biology (Clifton, N.J.) 01/2012; 907:411-42.
-
[show abstract]
[hide abstract]
ABSTRACT: In this article, we report on poly(amidoamine) dendrimers (PAMAM) as coupling agents for recombinant single-chain (ScFv) antibodies to nanoparticle (NP) labels, for use in immunoassay. We present a simple theory for the kinetics of particle capture onto a surface by means of an antibody-antigen reaction, in which the important parameter is the fraction of the particle surface that is active for reaction. We describe how increasing the generation number of the linking dendrimers significantly increased the fraction of the NP surface that is active for antigen binding and consequently also increased the assay kinetic rates. Use of dendrimers for conjugation of the NP to the antibody resulted in a significantly higher surface coverage of active antibody, in comparison with mono-valent linker chemistry. As a direct consequence, the increase in effective avidity significantly out-weighed any effect of a decreased diffusion coefficient due to the NP, when compared to that of a molecular dye-labelled antibody. The signal to noise ratio of the G4.5 dendrimer-sensitised nanoparticles out-performed the dye-labelled antibody by approximately four-fold. Particle aggregation experiments with the multi-valent antigen CRP demonstrated reaction-limited aggregation whose rate increased significantly with increasing generation number of the dendrimer linker.
The Analyst 06/2011; 136(12):2533-41. · 4.23 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: This paper presents an overview of development of a novel disposable plastic biochip for multiplexed clinical diagnostic applications. The disposable biochip is manufactured using a low-cost, rapid turn- around injection moulding process and consists of nine parabolic elements on a planar substrate. The optical elements are based on supercritical angle fluorescence (SAF) which provides substantial enhancement of the fluorescence collection efficiency but also confines the fluorescence detection volume strictly to the immediate proximity of the biochip surface, thereby having the potential to discriminate against background fluorescence from the analyte solution. An optical reader is also described that enables interrogation and fluorescence collection from the nine optical elements on the chip. The sensitivity of the system was determined with a biotin-avidin assay while its clinical utility was demonstrated in an assay for C-reactive protein (CRP), an inflammation marker.
Biomedical Microdevices 05/2011; 13(4):759-67. · 3.03 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Antibodies are ubiquitously deployed on in vitro diagnostic (IVD) platforms for detecting a panoply of analytes indicative of environmental and food contamination, residue adulteration and both veterinary and medical diagnostics. In the clinical realm, rapid and accurate determination of disease status is paramount. The significance of immunodiagnostic performance cannot be overemphasized and in many cases reliable diagnosis informs medical intervention which can mean the difference between patient recovery and demise. Cardiovascular disease (CVD) is the single biggest cause of adult mortality in the western world and principal burden on the healthcare services. Although the troponin (Tn) family, in particular troponin I (TnI), are regarded as the gold standard for diagnosis of myocardial damage, over the last decade much research has focused on the identification of alternative cardiac biomarker molecules that can either supplant or complement TnI metrics to add value to cardiac risk stratification criteria. In particular, markers that appear earlier than TnI in the pathophyisiology of cardiac disease are highly sought after. The subject of this addendum represents part of a broader challenge to deliver novel rapid point-of-care (POC) diagnostics to provide a chip-based multi-plexed platform for more comprehensive profiling of cardiac status with additive diagnostic and prognostic value. Specifically, it outlines proof-of-concept direct myeloperoxidase (MPO) detection, demonstrates the benefits of using recombinant antibodies in POC diagnostics and describes optimized strategies for generation of superior candidate antibody panels.
Bioengineered bugs 05/2011; 2(3):182-6.
-
[show abstract]
[hide abstract]
ABSTRACT: The use of optical biosensors for studying macromolecular interactions is gaining increasing popularity. In one study, 1,179 papers that involved the application of biosensor data were identified for the year 2007 alone (Rich and Myszka, J Mol Recognit 21:355-400, 2008), the sheer volume and variety of which present a daunting task for the burgeoning biosensor user to accumulate and decipher. This chapter is designed to provide the reader with the tools necessary to prepare, design, and efficiently execute a kinetic experiment on Biacore. It is written to guide the Biacore user through basic theory, system maintenance, and assay set-up while also offering some practical tips that we find useful for Biacore-based studies. Many kinetic-based screening assays require rigorous sample preparation and purification prior to analysis. To highlight these procedures, this protocol describes the kinetic characterisation of single chain Fv (scFv) antibody fragments from crude bacterial lysates using an antibody affinity capture approach. Even though we specifically describe the capture of HA-tagged scFv antibody fragments to an anti-HA tag monoclonal antibody-immobilised surface prior to kinetic analysis, the same methodologies are universally applicable and can be used for practically any affinity pair and most Biacore systems.
Methods in molecular biology (Clifton, N.J.) 01/2011; 681:403-18.
-
[show abstract]
[hide abstract]
ABSTRACT: The use of optical biosensors for studying macromolecular interactions is gaining increasing popularity. In one study, 1,179
papers that involved the application of biosensor data were identified for the year 2007 alone (Rich and Myszka, J Mol Recognit
21:355–400, 2008), the sheer volume and variety of which present a daunting task for the burgeoning biosensor user to accumulate
and decipher. This chapter is designed to provide the reader with the tools necessary to prepare, design, and efficiently
execute a kinetic experiment on Biacore. It is written to guide the Biacore user through basic theory, system maintenance,
and assay set-up while also offering some practical tips that we find useful for Biacore-based studies. Many kinetic-based
screening assays require rigorous sample preparation and purification prior to analysis. To highlight these procedures, this
protocol describes the kinetic characterisation of single chain Fv (scFv) antibody fragments from crude bacterial lysates
using an antibody affinity capture approach. Even though we specifically describe the capture of HA-tagged scFv antibody fragments
to an anti-HA tag monoclonal antibody-immobilised surface prior to kinetic analysis, the same methodologies are universally
applicable and can be used for practically any affinity pair and most Biacore systems.
Key wordsAntibody–Surface plasmon resonance–Biacore–Kinetics–Biosensor analysis–Protein–protein interactions.
12/2010: pages 403-418;
-
[show abstract]
[hide abstract]
ABSTRACT: During recent times, heart-type fatty acid binding protein (hFABP) has gained increasing credence as a promising cardiac biomarker. This is largely due to its rapid myocardial release and subsequent clearance kinetics, which are superior to those of myoglobin and offer an earlier diagnostic window than the troponins. Realization of its full diagnostic and prognostic potential is dependent on accessibility to robust hFABP-specific assays. Here we describe a rational strategy for generation and screening of hFABP-specific avian-derived recombinant antibodies. These antibodies were confirmed to be exquisitely specific for hFABP, with no cross-reactivity observed in a representative panel of the most homologous non-heart-type FABP isoforms. All of the antibodies tested exhibited single-figure nanomolar affinities, and their analytical potential was demonstrated in a simple inhibition enzyme-linked immunosorbent assay (ELISA) format that returned an impressive limit of quantitation (LOQ) value of 1.9 ng/ml. The cumulative results underline the potential value of these antibodies as enabling reagents for use in a variety of immunodiagnostic configurations.
Analytical Biochemistry 12/2010; 407(2):165-71. · 3.00 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Over the past 10 years, a growing field of research supporting the value of myeloperoxidase (MPO) as a prognostic indicator in acute cardiac pathophysiologies has emerged. The availability of a rapid and disposable MPO detection platform would enable research clinicians to more readily assess MPO indications for guiding therapy and also facilitate clinicians at the patient interface to readily adopt MPO testing and potentially drive more informed prognoses. Here we describe the isolation of a high-affinity avian MPO-specific recombinant antibody panel using phage display. Rapid isolation of a suitable single-chain variable fragment (scFv) antibody was facilitated using a surface plasmon resonance (SPR)-based "off-rate ranking" screening process. The selected scFv was then successfully incorporated into a rapid, simple, and sensitive one-step lateral flow immunoassay (LFIA) for the detection of MPO. This "one-step" feature of the developed assay was made possible by the scFv's strong affinity for MPO, obviating the need for sandwich signal enhancement steps. The assay's rapid performance was also further enhanced by exploiting the intrinsic enzymatic properties of MPO in its final detection. Use of the optimized LFIA facilitated the sensitive detection of MPO in MPO-depleted serum within clinically relevant reference ranges.
Analytical Biochemistry 10/2010; 410(1):1-6. · 3.00 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Recent trends in the development of analytical procedures are directed toward platforms and devices that are speedy, small, sensitive, and specific. However, these aims may require new reagents and approaches that are tailor-made for the application envisaged, or re-tooling of existing systems. Whichever approach is taken, the problems and demands remain similar. They include non-specific binding and its elimination, oriented immobilization of ligands and other molecules, matrix effects, the need for sample “clean-up,” single or multiple use, miniaturization, microfluidic needs, ease-of-use, user, legislator and consumer appreciation, acceptance and requirements, and cost considerations. These and other issues will be critically analyzed in the light of recent achievements and the potential to overcome current obstacles will be discussed.
Analytical Letters 07/2010; 43(10-11):1630-1648. · 1.02 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The lack of a clear correlation between design and protection continues to present a barrier to progress in vaccine research. In this article, we outline how surface plasmon resonance (SPR) biosensors are emerging as tools to help resolve some of the key biophysical determinants of protection and, thereby, facilitate more rational vaccine design campaigns. SPR technology has contributed significantly to our understanding of the complex biophysical determinants of HIV neutralization and offers a platform for preclinical evaluation of vaccine candidates. In particular, the concept of reverse-engineering HIV vaccine targets based on known broadly neutralizing antibody modalities is explored and extended to include other infectious diseases, such as malaria and influenza, and other diseases such as cancer. The analytical capacity afforded by SPR includes serum screening to monitor immune responses and highly efficient quality-control surveillance measures. These are discussed alongside key technological advances, such as developments in sample throughput, and a perspective predicting continued growth and diversification of the role of SPR in vaccine development is proposed.
Expert Review of Vaccines 06/2010; 9(6):645-64. · 4.25 Impact Factor
-
Nature Nanotechnology 01/2010; 5(1):9-10. · 27.27 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Currently, the reliable detection and quantification of a multitude of different analytes is crucial in many applications and settings. Biosensors have revolutionised diagnostics for use in point-of-care testing (POC), the detection of food and environmental contaminants, biological warfare agents, illicit drugs and human/animal disease markers. Antibodies continue to play a pivotal role in many sensor devices due to their exquisite specificity for their cognate antigens. In this review current biosensor platforms employing antibodies for molecular recognition are briefly described. The use of molecular biological techniques for the generation and improvement of antibodies is critically examined. Such recombinant antibodies possess improved attributes for use in biosensor development in terms of design, stability, affinity and specificity.
Seminars in Cell and Developmental Biology 03/2009; 20(1):10-26. · 6.65 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Cardiovascular disease (CVD) is the single greatest cause of adult mortality in the western world and, consequently, places a massive burden on healthcare services and the economy. Lifestyles, lack of clearly defined risk assessment criteria, consistently high incidences of misdiagnosis and inappropriate referrals, all contribute significantly to this problem. It also correlates directly with inefficient or non-accessible early detection systems. Over the last decade much research has focused on the identification of cardiac biomarkers that can be used for the detection of cardiac distress and that add value to current risk stratification criteria. An exposition of some of the most consistently cited biomarkers is provided and their current status and potential value as early CVD risk predictors, more accurate diagnostic markers of acute myocardial damage and as reliable prognostic indicators, is evaluated. The particular importance of early prediction and the integral role that point-of-care (POC) testing is expected to play in the future of cardiac care is critically discussed.
Clinical biochemistry 03/2009; 42(7-8):549-61. · 2.02 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Advances in molecular evolution strategies have made it possible to identify antibodies with exquisite specificities and also to fine-tune their biophysical properties for practically any specified application. Depending on the desired function, antibody/antigen interactions can be long-lived or short-lived and, therefore, particular attention is needed when seeking to identify antibodies with specific reaction-rate and affinity properties. Surface plasmon resonance (SPR) biosensors routinely generate sensitive and reliable kinetic data from antibody/antigen interactions for both therapeutic and diagnostic applications. However, many kinetic-based screening assays require rigorous sample preparation and purification prior to analysis. To ameliorate this problem, we developed a rapid and reliable assay for characterising recombinant scFv antibody fragments, directly from crude bacterial lysates. Ninety-six scFv antibodies derived from chickens immunised with C-reactive protein (CRP) were selected by phage display and evaluated using the Biacore A100 protein interaction array system. Antibodies were captured from crude bacterial extracts on the sensor chip surface and ranked based on the percentage of the complex left (% left) after dissociation in buffer. Kinetic rate constants (k(a) and k(d)) and affinity (K(D)) data were obtained for six clones that bound monomeric CRP across a broad affinity range (2.54 x 10(-8) to 3.53 x 10(-10) M). Using this assay format the A100 biosensor yielded high quality kinetic data, permitting the screening of nearly 400 antibody clones per day.
Journal of Immunological Methods 07/2007; 323(2):172-9. · 2.20 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: This paper describes a biosensor-based method for detection of fungal spores using surface plasmon resonance (SPR). The approach involves the use of a mouse monoclonal antibody (Pst mAb8) and a SPR sensor for label-free detection of urediniospores from the model organism Puccinia striiformis f.sp. tritici (Pst). In the subtractive inhibition assay, urediniospores and Pst mAb8 were mixed, urediniospore-bound Pst mAb8 removed by centrifugation and the remaining Pst mAb8 quantified using the SPR sensor. Assay conditions were optimised and a detection limit of 3.1 x 10(5)urediniospores/ml was achieved. Spiked Pst samples were further examined in a background of a related spore and it was found that Pst detection was possible in this mixture. This study represent the first use of SPR technology for fungal spore detection as well as the first report of a successful biosensor-based detection strategy for Pst.
Biosensors and Bioelectronics 06/2007; 22(11):2724-9. · 5.60 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The fungal pathogen Pst causes yellow rust disease in wheat plants leading to crop losses. The organism spreads by releasing wind-dispersed urediniospores from infected plants. In this study a library of novel monoclonal antibodies (mAbs) was developed against Pst urediniospores. Nine mAb-producing cell lines were cloned and their cross-reactivities characterised against a panel of airborne fungal spores representing genera commonly found in the same environment as Pst. Two specific mAbs were used to develop a competitive ELISA (Pst mAb4) and a subtractive inhibition ELISA (Pst mAb8). Standard curves for both assays had good intra- and interday reproducibility. The subtractive inhibition ELISA had greater sensitivity with a detection limit of 1.5 x 10(5) spores ml(-1). Cross-reactivity studies of Pst mAb8 in the subtractive inhibition ELISA, showed reaction with other Puccinia spores only, suggesting that common epitopes exist within this genus. The biosensor-compatible Pst mAb8 assay principle developed in this study has the potential to be implemented in future 'label-free' in-the-field systems for Pst detection.
Mycological Research 04/2007; 111(Pt 3):332-8. · 2.81 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Listeria monocytogenes is an important food-borne pathogen with an extremely high mortality rate (approximately 30%). Therefore, a highly sensitive, reproducible and rapid assay for its detection is vital. L. monocytogenes cells employ two surface bound proteins, Internalin A (InlA) and Internalin B (InlB) to promote invasion into host cells. Recombinant forms of both proteins were previously cloned and expressed in Escherichia coli. In this paper we describe how the InlB protein was sub-divided into three shorter overlapping peptide fragments yielding truncated functional protein of M(R) 23, 35 and 45 kDa, respectively. Purification of the InlB fragments by immobilised metal affinity chromatography (IMAC) was optimised and confirmed by electrophoresis and Western blotting. Identification of the antibody binding regions was achieved by probing the expressed polypeptide domains with a panel of antibodies and antibody fragments. The cloned peptide fragments were also used to develop novel fluorescence-based immunoassays incorporating quantum dots. The application of quantum dot-labelled anti-InlA monoclonal antibodies for immunostaining L. monocytogenes was also demonstrated.
International Journal of Biological Macromolecules 09/2006; 39(1-3):127-34. · 2.45 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A panel of hybridomas was produced using intact Listeria monocytogenes serotype 1/2a cells as the immunogen. An IgG2a monoclonal antibody (mAb) 'mAb2B3' was isolated that reacted with L. monocytogenes but not with a representative panel of related Listeria spp. and non-Listeria spp. Binding activity was greatest against L. monocytogenes serotype 1/2a and was significantly enhanced when cells were prepared in Listeria enrichment broth (LEB). The reactive epitope was deduced, by immunoblot analysis, to be a surface localised protein of approximately 80 kilodaltons (kDa), putatively assumed to be internalin A (InlA). Recombinant InlA protein was subsequently expressed in Escherischia coli. When crude E. coli cell lysates were subjected to immunoblot analysis, it was demonstrated that the mAb bound specifically to the heterologously expressed recombinant InlA protein, thus confirming the specificity of the mAb. The mAb was further evaluated in a series of enzyme-linked-immunosorbent assay (ELISA)-based formats and in a surface plasmon resonance (SPR)-based biosensor platform. Both configurations were capable of differential identification of virulent L. monocytogenes at concentrations greater than or equal to 1x10(7) cells/ml. Notwithstanding the apparent insensitivity, the results indicate that InlA could be exploited as a marker for highly specific confirmatory identification of pathogenic L. monocytogenes following primary enrichment of suspect food samples, using the anti-InlA antibody 'mAb2B3', described herein.
Journal of Microbiological Methods 09/2006; 66(2):294-312. · 2.09 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Purpose of review: This review examines the current and future potential applications of biosensor-based technologies in the postharvest analysis of fruit, vegetables and other crops. The basic format of sensors is summarised and key elements in their generation highlighted. Difficulties with current sensor formats are described and approaches to improve their utility are outlined. Examples of the applications of sensors, particularly surface plasmon resonancebased systems, are given to demonstrate the current and future potential of the technology to overcome problems associated with analytical approaches presently used.Limitations: The review is limited by the relatively small number of papers available related to applications. However, there are clear opportunities available and significant research is beginning to concentrate on key issues and already there is clear demonstration of potential.Directions for future research: Future developments of miniaturised sensors for the performance of multi-analyte, real-time detection e.g.biochips and arrays, using high-throughput systems linked to automatic responses, independent of an operator, with wireless control, are discussed.
Stewart Postharvest Review 09/2005; 1(3):1-18.
